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Abstract 
Background: Evidence suggests that patients with bipolar disorder (BD) experience biological rhythm disturbances; 
however, no studies have examined the impact of this disruption on quality of life (QOL). The aim of this study is to 
investigate the influence of biological rhythm, depressive symptoms, sleep quality, and sleep medication use on QOL 
in BD.Author details: Journal instruction requires author’s email address; however, this was not provided for Cudney, 
Streiner, Minuzzi, Sassi. A temporary email address was presented. Please supply the correct email address of the said 
authorLauren Cudney: laurencudney@gmail.com David Streiner: streiner@mcmaster.ca Luciano Minuzzi: minuzzi@
mcmaster.ca Roberto Sassi: sassir@mcmaster.ca
Methods: Eighty BD subjects (44 depressed and 36 euthymic) completed questionnaires assessing QOL (WHOQOL-
BREF), biological rhythm disruption (BRIAN), depressive symptoms (MADRS), and sleep quality (PSQI). The impact of 
biological rhythm disturbance, depressive symptoms severity, sleep quality, and sleep medication use on QOL was 
determined with multiple regression analyses.
Results: BRIAN (β = −0.31, t = −2.73, p < 0.01), MADRS (β = −0.30, t = −2.93, p < 0.01), and sleep medication use 
(β = −0.45, t = −2.55, p < 0.05) were significant predictors of QOL in this model (F4, 75 = 20.28; p < 0.0001). The rela-
tionship of these factors with subdomains of QOL showed that poorer social QOL was associated with greater biologi-
cal rhythm disturbance (β = −0.43, t = −3.66, p < 0.01) and sleep medication use (β = −0.49, t = −2.35, p < 0.01), 
providing support for the social rhythm theory of BD. Physical QOL was associated with depression (β = −0.30, 
t = −2.93, p < 0.01) and biological rhythm disruption (β = −0.31, t = −2.73, p < 0.01). Main limitations include the 
cross-sectional assessment and the lack of objective measures of biological rhythms in relation to QOL.
Conclusions: Disruption in biological rhythm is associated with poor QOL in BD, independent of sleep disturbance, 
sleep medication use, and severity of depression. Treatment strategies targeting regulation of biological rhythms, such 
as sleep/wake cycles, eating patterns, activities, and social rhythms, are likely to improve QOL in this population.
Keywords: Bipolar disorder, Circadian rhythm, Quality of life, Sleep
© 2016 Cudney et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Bipolar disorder (BD) is a complex and debilitating dis-
order that affects about 4  % of the general population 
(Merikangas et al. 2007). BD was previously considered a 
cyclic disorder consisting of alterations between depres-
sive or manic episodes and periods of euthymia. More 
recently, there has been a reconceptualization of BD as 
a chronic and multisystemic disorder, given that a sub-
stantial proportion of symptoms of BD do not completely 
remit even when patients are not experiencing an acute 
mood episode (Leboyer and Kupfer 2010). Cognitive 
impairment, difficulties in relationships, and social and 
occupational functioning also often persist during clini-
cal remission (Giglio et al. 2010). Therefore, it is critical 
to understand the mechanisms that may contribute to 
the inter-episodic dysfunction of BD. In this regard, some 
of the most common problems observed during periods 
of remission are sleep and circadian rhythm disturbances 
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(Harvey et  al. 2005). Studies based on subjective meas-
ures of sleep quality showed that remitted BD subjects 
report many of the same disturbances as individuals with 
primary insomnia, such as decreased sleep efficiency, ele-
vated sleep-related anxiety (Harvey et al. 2005), and more 
daytime sleepiness (Amand et  al. 2013). A recent study 
showed that euthymic BD subjects experienced signifi-
cantly poorer sleep quality compared to healthy controls, 
based on multiple components of a subjective measure 
of sleep quality (Rocha et al. 2013). Perhaps more impor-
tantly, sleep disturbance is the most commonly reported 
prodromal symptom of mania and the sixth most promi-
nent for depression (Jackson et al. 2003).
Sleep/wake cycles follow a nearly 24-h rhythm known as 
circadian rhythm. Circadian rhythms can be entrained by 
external cues known as zeitgebers. Zeitgebers can be either 
physical stimuli (e.g., light) or social events such as tim-
ing of general activities or meals (Juda et  al. 2013; Patton 
and Mistlberger 2013). Actigraphic assessments of biologi-
cal rhythms in euthymic BD subjects showed greater vari-
ability in circadian activity compared to controls (Jones et al. 
2005), variability of sleep duration (Millar et  al. 2004), and 
lower daily activity levels (Salvatore et  al. 2008). A recent 
study used actigraphy in young people with recent onset of a 
mood disorder, and results suggest that less robust circadian 
rhythmicity was associated with longer duration of illness 
and increasing symptom severity, suggesting this as a trait 
marker for young people at risk for BD (Grierson et al. 2016). 
Measurement of melatonin secretion, the primary hormone 
for circadian rhythm synchronization, also indicates changes 
in circadian rhythms in BD (Nathan et al. 1999). Ehlers et al. 
(1988) first proposed the social zeitgeber theory, in which 
individuals with BD are more vulnerable to social routine 
and sleep disturbances that may predispose them to the 
onset of mood episodes. Stressful life events, which disrupt 
routines and social rhythms (zeitgebers), can put individuals 
with BD at risk for a mood episode (Shen et al. 2008). Pinho 
et al. (2015) were the first to show that as depressive symp-
tom severity increase, so do biological rhythm disturbance 
in BD patients. A recent study in a drug-naïve community 
sample showed that biological rhythms were more disturbed 
in subjects with BD compared to controls (Duarte Faria 
et al. 2015). Taken together, these studies show that distur-
bances in sleep and biological rhythms are seen throughout 
the course of the disorder, suggesting this disturbance can be 
seen as both state and trait markers of BD.
Quality of life (QOL) is a subjective measure of satis-
faction with aspects of life such as physical and psycho-
logical health, social relationships, and environment 
(The WHOQOL Group 1995), and has consistently 
been shown to be decreased in BD patients (Micha-
lak et  al. 2005). Many of these QOL domains overlap 
with aspects that contribute to social and biological 
rhythms. For instance, Giglio et  al. (2008) found that 
euthymic BD subjects with symptoms of insomnia had 
lower QOL than those without sleep disturbance. It has 
been suggested that sleep alterations may contribute to 
impaired QOL in BD possibly due to the effects of poor 
sleep quality on concentration, cognition, and memory 
(Giglio et al. 2008). Severity of depressive symptoms is 
also a strong predictor of poor QOL in BD (Amini and 
Sharifi 2012; Yatham et al. 2004). In fact, depressed BD 
patients experience more impairment in QOL than uni-
polar depressed patients, even when severity of depres-
sion was taken into account (Berlim et al. 2004). It has 
been suggested that cognitive distortions experienced 
during acute depression may have a negative impact on 
subjective ratings of QOL (Michalak et al. 2005).
As disturbances in sleep and biological rhythms are 
prominent features of BD, a better understanding of how 
these symptoms relate to overall sense of well-being and 
QOL is required. To the best of our knowledge, the inter-
play of depressive symptoms, sleep quality, and biological 
rhythms on QOL has not been studied in euthymic and 
depressed BD subjects. In addition, many psychotropic 
drugs used in the treatment of BD can affect sleep, but it 
is still unclear how these drugs may moderate the impact 
of sleep and biological rhythms on QOL. The objective 
of the present study was to examine the impact of sleep, 
biological rhythms, sleep medication use, and severity 
of depression on QOL in a well-characterized sample of 
euthymic and depressed BD subjects. The impact of these 
factors was measured on overall and specific domains of 
QOL such as physical, psychological, social relationships, 
and environment. We hypothesized that abnormalities 
in biological rhythms would be independently associated 
with poor QOL in individuals with BD.
Methods
Participants
Eighty patients with BD type I (n = 58), BD type II (n = 21), 
or NOS (n  =  1) were recruited from the Mood Disor-
ders Program and Women’s Health Concerns Clinic at 
St. Joseph’s Healthcare Hamilton, Ontario. The study was 
approved by the ethics committee of St. Joseph’s Healthcare 
Hamilton and Hamilton Health Sciences. All participants 
gave written informed consent to take part in the study, in 
accordance with declaration of Helsinki. The diagnosis of 
BD was confirmed with the structured clinical interview 
for the DSM-IV (SCID-I), as assessed by a trained research 
nurse and graduate student. Patients with BD were 
included in the study if they either met criteria for a current 
major depressive episode (n = 44) or if they did not meet 
criteria for any current mood episode (n = 36) according to 
the SCID-I. Patients were excluded if they met criteria for a 
current hypomanic, manic, or mixed episode.
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Clinical instruments
QOL was measured using the World Health Organization 
Quality of Life assessment (WHOQOL-BREF), which con-
sists of 26 items, covering four domains of QOL: physical 
health (7 items), psychological (6 items), social relationships 
(3 items), and environment (8 items), with greater scores 
indicating better QOL (The WHOQOL Group 1995). This 
scale has been validated and widely used in BD research 
(Michalak et  al. 2005). The Montgomery-Åsberg Depres-
sion Rating Scale (MADRS) was employed to measure 
depressive symptom severity (Montgomery and Asberg 
1979). Degree of biological rhythm disruption was meas-
ured with the Biological Rhythm Interview of Assessment in 
Neuropsychiatry (BRIAN). The BRIAN consists of 18-items 
measuring sleep, overall activities, social rhythm, and eating 
behavior scored from 1 (no difficulties) to 4 (serious difficul-
ties), with greater scores indicating more biological rhythm 
disruption. This scale has been validated in BD patients in 
its ability to discriminate euthymic BD and controls (Giglio 
et al. 2009). The BRIAN scale has previously been used in 
conjunction with measures of cognitive functioning in 
euthymic BD patients and showed that biological rhythm 
disruption was a predictor of poorer functioning (Giglio 
et al. 2010). Pittsburgh Sleep Quality Index (PSQI) was used 
to measure subjective sleep quality (Buysse et  al. 1989). 
The PSQI is a standardized self-rating questionnaire which 
evaluates seven components of sleep quality, including sub-
jective sleep quality, sleep latency, sleep duration, habitual 
sleep efficiency, sleep disturbances, use of sleeping medi-
cation, and daytime dysfunction. To more closely examine 
the use of sleep medications on QOL, a separate factor was 
included based on the answer to “use of sleep medication” 
(component 6). Sleep medication status was categorized as 
‘yes’ if participants reported using sleep medications either 
‘once or twice a week’ or ‘more than three times per week’ 
on component 6 of the PSQI. This response was cross-
referenced with medications recorded for each participant 
during the clinical assessments (including bedtime use of 
benzodiazepines, zopiclone, quetiapine, or over-the-counter 
compounds such as melatonin).
Statistical analysis
All analyses were performed with R (Version 3.1.0, R Devel-
opment Core Team, 2014). Multiple regression analysis was 
performed using MADRS, PSQI, BRIAN, and sleep medica-
tion status as predictors, and overall WHOQOL-BREF scores 
as the dependent variable. To avoid colinearity between 
PSQI and sleep medication factor, the PSQI subscale for “use 
of medication” (component 6) was dropped from the total 
PSQI score, as previously done by (Giglio et al. 2010). Since 
the sample is 80 % females, sex was added to the model but 
was not a significant factor (p > 0.05). Assumptions of linear 
regression were tested with Shapiro–Wilk test (normality), 
partial residuals plots (linearity), Durbin–Watson test (inde-
pendence of errors), non-constant error variance (homosce-
dasticity), and variance inflation factor test (multicollinearity). 
Each model met the assumption of multicollinearity, meaning 
each of the regressors was independent from each other.
To further investigate the relationships involved in the 
overall QOL, multiple linear regressions for each sepa-
rate subdomain of the WHOQOL-BREF (physical health, 
psychological health, social relationships, and environ-
ment QOL) were performed, including predictors that 
were significant with overall WHOQOL-BREF scores. 
In order to control for multiple comparisons, Bonferroni 
correction was set at p = 0.05/4 = 0.0125.
Results
Demographic and clinical data are displayed in Table 1. 
In patients with BD, lower QOL was correlated with 
greater depressive symptoms (rP  =  −0.60, 95  % CI 
[−0.72, −0.43], p < 0.001), greater biological rhythm dis-
ruption (rP = −0.60, 95 % CI [−0.72, −0.44], p < 0.001), 
and poorer sleep quality (rP = −0.55, 95  % CI [−0.68, 
−0.37], p  <  0.001). Results from the regression analy-
ses are reported in Table  2. Multiple regression analy-
ses indicated that BRIAN, MADRS, PSQI, and sleep 
medication use explained 49.4 % of the variance in total 
WHOQOL-BREF scores (F4,75 =  20.28; p  <  0.0001). In 
this model, BRIAN (β  =  −0.31, t  =  −2.73, p  <  0.01), 
MADRS scores (β = −0.30, t = −2.93, p  <  0.01), and 
sleep medication use (β = −0.45, t = −2.55, p  <  0.05) 
were independent predictors of QOL, whereas PSQI 
scores were not associated with overall QOL (p > 0.05).
Next, in order to better understand if depressive symp-
toms, biological rhythms, and medication use were associ-
ated with physical, social, psychological, and environmental 
QOL, multiple linear regressions for each WHOQOL-BREF 
domain were performed with MADRS, BRIAN, and sleep 
medication status as predictors (Table 3a–d):
Physical QOL
Physical QOL was independently associated with both 
MADRS (β  =  −0.36, t  =  −3.21, p  <  0.01) and BRIAN 
scores (β = −0.28, t = −2.58, p < 0.01; Table 3a).
Psychological QOL
Psychological QOL was strongly associated with MADRS 
(β = −0.66, t = −7.31, p < 0.01), but not with BRIAN or 
sleep medication use (both p > 0.05; Table 3b).
Social QOL
Social QOL was independently associated with BRIAN 
(β = −0.43, t = −3.66, p  <  0.01) and sleep medication 
status (β  =  −0.49, t  =  −2.35, p  <  0.01), but not with 
MADRS (p > 0.05; Table 3c).
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Environment QOL
Environment QOL scores were transformed (squared) 
to meet the assumption of normality. Environment 
QOL was associated with BRIAN (β = −0.30, t = −2.36, 
p < 0.05) and sleep medication use (β = −0.56, t = −2.43, 
p  <  0.05; Table  3d). However, neither of these associa-
tions were considered significant after Bonferroni correc-
tion for multiple comparisons (p = 0.0125).
Discussion
This is the first study to investigate the relationship 
between biological rhythms and QOL in individuals 
with BD. The novel finding of this study is that self-
reported disruption in biological rhythms was strongly 
associated with poor overall QOL in individuals with 
BD, independent of severity of depressive symptoms, 
sleep disturbance, and use of sleep medications. Results 
from the overall QOL regression (Table  2) show that 
despite a significant correlation between total WHO-
QOL-BREF scores and PSQI scores, subjective sleep 
quality is not significantly associated with overall QOL 
when depression severity, rhythm disruption, and sleep 
medication status are taken into account. BRIAN scale 
contains five questions that measure sleep disturbance 
as it contributes to biological rhythm disruption. It is 
likely that these sleep questions within the BRIAN scale 
are sensitive enough to account for the impact of sleep 
quality on QOL variation in patients with BD. Previous 
research implicated biological rhythm disturbance in 
various domains of functioning that are directly or indi-
rectly related to QOL. For instance, Giglio et al. (2010) 
found that overall functioning (including measures of 
autonomy, work, cognition, financial, and interper-
sonal issues) was best predicted by biological rhythms 
as measured by BRIAN in euthymic BD subjects. In a 
large multi-center study, we have recently found that 
biological rhythms and depressive symptom severity 
were independently associated with worse psychoso-
cial functioning in BD patients (Pinho et al. 2015). Even 
in periods of euthymia, BD subjects tend to report a 
later daily first social and work contact as compared to 
matched controls (Jones et al. 2005). Similarly, occupa-
tional functioning was more quickly improved in BD 
patients after therapy focused on regulation of social 
rhythms (interpersonal social rhythm therapy; IPSRT) 
compared to a psychoeducational therapy (Frank et al. 
2008). Our results suggest that therapies targeting the 
regulation of biological rhythms such as IPSRT, exer-
cise, psychoeducation, light therapy, sleep hygiene, cog-
nitive behavioral therapy for insomnia, etc., may have a 
direct impact in improving QOL along with symptom 
recovery in BD. Considering that biological rhythm dis-
turbance predicted decreased QOL better than sleep 
quality alone, this suggests that other factors associated 
with biological rhythms like eating patterns, activities, 
and social rhythms also play an important role in over-
all QOL.
Table 1 Demographic and  clinical characteristics of  par-
ticipants
Variable Bipolar sample (n = 80)
Mean age, years (SD) 42.62 (12.88)
 Range 20–66
Sex
 Female 64 (80.0%)
 Male 16 (20.0%)
Occupation status
 Employed 38 (47.5 %)
 Unemployed 38 (47.5 %)
 No data 4 (5.0 %)
 Education, years (SD) 15.24 (3.11)
Current psychiatric comorbidities, n (%)
 Alcohol/substance abuse 11 (13.8 %)
 Eating disorders 2 (2.5 %)
 Generalized anxiety disorder 11 (13.8 %)
 Obsessive compulsive disorder 4 (5.0 %)
 Panic disorder 7 (8.8 %)
 Post traumatic stress disorder 10 (12.5 %)
 Social phobia 12 (15.0 %)
 Specific phobia 3 (3.8 %)
Psychiatric medications, n (%)
 Mood stabilizers 47 (58.8 %)
 Anti-psychotics 40 (50.0 %)
 Antidepressants 44 (55.0 %)
 Anxiolytics 40 (50.0 %)
Sleep medication use
 Yes 54 (67.5 %)
 No 26 (32.5 %)
Mean total WHOQOL (SD) 202.91 (61.51)
 Range 75–326
Mean WHOQOL-physical QOL (SD) 51.35 (17.69)
 Range 6–88
Mean WHOQOL-psychological QOL (SD) 41.11 (20.31)
 Range 0–81
Mean WHOQOL-social QOL (SD) 44.74 (25.30)
 Range 0–100
Mean WHOQOL-environmental QOL (SD) 65.71 (16.48)
 Range 19–100
Mean MADRS (SD) 16.76 (10.55)
 Range 0–38
Mean BRIAN (SD) 47.69 (10.06)
 Range 29–69
Mean PSQI (without component 6) (SD) 8.35 (3.88)
 Range 2–20
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Next, we investigated how the BRIAN, MADRS, and 
sleep medication use impacted each subdomain of QOL. 
We found that worse social QOL was significantly asso-
ciated with biological rhythm disturbance (BRIAN) and 
use of sleep medications, but not with depression sever-
ity. Social zeitgebers that contribute to maintaining regu-
lar biological rhythms include personal relationships, and 
social demands and tasks (Frank et al. 2000), which are all 
directly associated with social relationship satisfaction. 
Given the findings that individuals with BD experience 
insecure attachment and lower levels of social support 
(Greenberg et  al. 2014), it is to be expected that there 
may be alterations in social zeitgebers in these patients. 
This result is also consistent with the social zeitgeber 
theory which implies that disruptions in social cues and 
daily social interactions are associated with worse clini-
cal outcomes (Ehlers et al. 1988). IPSRT utilizes the social 
rhythm metric for sleep/wake times, mealtimes, time 
spent with others, and work periods to understand where 
and when the rhythm disturbance is occurring (Frank 
et  al. 2000). A recent trial of IPSRT in treating young 
people with BD found that targeting the stabilization of 
Table 2 Multiple linear regression analysis on total WHOQOL-BREF scores
Adj. r2 = 0.494, f = 20.28, df = 4, 75, p < 0.0001
* Significant at p < 0.05









t value Pearson’s r
MADRS −0.30** 0.10 −1.73 0.59 −2.93 −0.60**
BRIAN −0.31** 0.11 −1.87 0.69 −2.73 −0.60**
PSQI (no meds) −0.16 0.11 −2.61 1.70 −1.54 −0.55**
Sleep meds −0.45* 0.17 −27.47 10.76 −2.55 n/a
Table 3 Multiple linear regression analysis on WHOQOL-BREF (a) physical, (b) psychological, (c) social, and (d) environ-
mental QOL subdomain
a Adj. r2 = 0.3563, f = 15.57, df = 3, 76, p < 0.000
b Adj. r2 = 0.5829, f = 37.8, df = 3, 76, p < 0.0001
c Adj. r2 = 0.2703, f = 10.75, df = 3, 76, p < 0.0001
d Adj. r2 = 0.1171, f = 4.49, df = 3, 76, p < 0.01
* Significant at p < 0.05









t value Pearson’s r
(a) Physicala
 MADRS −0.36** 0.11 −0.60 0.19 −3.21 −0.55**
 BRIAN −0.28** 0.11 −0.50 0.19 −2.58 −0.50**
 Sleep Meds −0.33 0.20 −5.88 3.47 −1.69 n/a
(b) Psychologicalb
 MADRS −0.66** 0.09 −1.27 0.17 −7.31 −0.76**
 BRIAN −0.16 0.09 −0.33 0.18 −1.85 −0.54**
 Sleep Meds −0.10 0.16 −2.11 3.2051 −0.66 n/a
(c) Socialc
 MADRS −0.07 0.12 −0.16 0.29 −0.58 −0.36**
 BRIAN −0.43** 0.12 −1.07 0.29 −3.66 −0.49**
 Sleep Meds −0.49** 0.21 −12.41 5.28 −2.35 n/a
(d) Environmentald
 MADRS 0.06 0.13 12.56 25.68 0.49 −0.15
 BRIAN −0.30* 0.13 −62.46 26.42 −2.36 −0.28*
 Sleep Meds −0.56* 0.23 −1154.34 475.27 −2.43 n/a
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social rhythms resulted in improved social functioning 
(Inder et al. 2014). Whether or not the benefit of IPSRT 
translates into better overall QOL remains to be studied. 
In addition, future studies that directly assess the associa-
tion between biological rhythms and social factors such 
as attachment, intimacy, and perceived social support are 
required. Overall, these results provide evidence for the 
importance of maintaining regular daily routines, and in 
turn biological rhythms, for improving life satisfaction in 
social relationships in patients with BD.
We also found that physical QOL was independently 
associated with biological rhythm disruption and depres-
sive symptom severity. BD is conceptualized as a multi-
systemic chronic illness associated with higher medical 
burden such as increased rates of cardiovascular dis-
ease, obesity, diabetes, etc. (Leboyer and Kupfer 2010). A 
recent study found that BD patients had poorer physical 
health than healthy controls, even when sleep and physi-
cal activity were similar between the groups (McGlinchey 
et al. 2014). Another study investigating the relationship 
between social and circadian rhythm regulation and 
physical health in healthy individuals showed that greater 
discrepancies between social and circadian rhythms 
resulted in higher cortisol levels, poorer sleep, and 
greater cardiovascular risk factors (Rutters et  al. 2014). 
To our knowledge, the relationship between biological 
rhythms and physical health has not been studied in BD. 
Understanding the mechanisms and neurobiology of this 
relationship is an important future direction of research 
in this field.
In our study, use of sleep medications was associated 
with poor overall QOL in BD (Table  2). The impact of 
sleep medication on individual domains of QOL was 
stronger for social QOL. Previous studies found an 
association between sleep medication use and impaired 
physical, but not psychological QOL in individuals with 
and without insomnia (Sasai et  al. 2010). However, our 
results do not show a relationship between sleep medi-
cation use and physical QOL in BD patients. This may 
be a valid comparison to our sample of BD subjects, 
since sleep disturbances commonly observed in peri-
ods of euthymia in BD are comparable to those seen in 
individuals with primary insomnia (Harvey et al. 2005). 
Therefore, it is possible that the use of sleep medications 
is associated with poor QOL in BD because more severe 
forms of BD have greater sleep disturbances, which 
would, in turn, increase the need for use of sleep aids. 
Side effects of sleep aids such as sedation, fatigue, and 
dizziness may also play a role in decreasing QOL. Nota-
bly, preclinical studies found that mood stabilizers, such 
as lithium and valproate, can regulate the expression of 
circadian rhythm genes (Johansson et al. 2011; Yin et al. 
2006). This is consistent with human studies showing 
that these mood stabilizers reduce the melatonin light 
sensitivity in healthy volunteers (Hallam et al. 2005a, b). 
Unfortunately, the cross-sectional nature of our study 
does not allow us to determine the directionality of this 
relationship.
Finally, we replicated previous findings that the sever-
ity of depressive symptoms is an independent predictor 
of poor QOL (Michalak et al. 2005). Yatham et al. (2004) 
previously showed that QOL was inversely correlated 
with severity of depression in both unipolar and bipolar 
depression. However, it is worth mentioning that QOL is 
not merely an inverse measure of depression, since QOL 
improvements typically lag after remission of depressive 
symptoms (Murray and Michalak 2012). For instance, 
a study on the treatment of BD depression with quetia-
pine found that improvement in QOL was positively 
correlated with improvement in depressive and anxiety 
symptoms and sleep quality, and that this relationship 
increased over time (Endicott et  al. 2008). We are not 
aware of any study reporting longitudinal investigation of 
the impact of circadian rhythm improvement on QOL.
Some of the main limitations of our study include the 
cross-sectional design and the lack of objective measures 
of biological rhythms in relation to QOL. Another limita-
tion is that BD subjects experiencing manic, hypomanic, 
or mixed episodes were excluded. Recent studies found 
that reports of QOL during manic and hypomanic epi-
sodes tend to be less impaired than during depressive or 
mixed states (Jansen et al. 2013; Michalak et al. 2013). As 
disturbance of circadian rhythms have also been associ-
ated with onset of manic episodes (Jackson et al. 2003), 
studies on the impact of biological rhythm disruption 
on QOL in manic/hypomanic subjects are warranted. A 
further limitation of our study is that participants with 
comorbid psychiatric diagnoses were included in the 
study (see Table  1), which may influence these results. 
Comorbid anxiety and substance/alcohol abuse or 
dependence are common in BD, and these illnesses are 
known to influence QOL; however, the influence on cir-
cadian rhythms remains to be studied.
A future direction of the present study is to correlate 
the subjective measures of biological rhythm (BRIAN) 
with objective measures of circadian rhythm disturbance, 
such as actigraphy. This would help in understanding 
whether disrupted schedules of sleep/wake cycles, meal 
timing, social rhythms, etc., are captured as disruptions 
in circadian rhythm measures. The BRIAN has previ-
ously been associated with increased levels of oxidative 
stress in BD patients (Cudney et  al. 2014), but has not 
been evaluated with other biological measures. Sleep 
and circadian assessment with dim light melatonin 
onset (DLMO) and actigraphy have recently been stud-
ied in youth with mood symptoms: Results showed that 
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disturbances in rhythms of melatonin and sleep quality 
differed in early stages of mood disorder (Naismith et al. 
2012). DLMO was not associated with severity of depres-
sion or sleep quality rating scales (Naismith et al. 2012). 
Other studies have found that components of actigraphic 
measurements correlated with subjective ratings of total 
sleep time (Gonzalez et al. 2013), sleep latency, and phase 
preference (Boudebesse et  al. 2014). Future studies are 
needed to evaluate whether objective measures of circa-
dian rhythms such as melatonin/DLMO and actigraphic 
measures correspond with BRIAN scores.
Conclusions
In conclusion, we found that self-reported biological 
rhythms were strongly associated with QOL, independ-
ent  of   severity of depressive symptoms, sleep quality, 
and use of sleeping aids in a sample of well-character-
ized euthymic and depressed BD subjects. Social QOL 
was particularly associated with biological rhythm dis-
turbances, providing further evidence for social rhythm 
theory of BD. Our study suggests that biological rhythms 
may have a direct impact on QOL, which highlights 
the importance of interventions that target circadian 
rhythms in combination with pharmacotherapy in BD. 
Further studies investigating the neurobiology behind 
circadian rhythm disturbance in BD, and how pharmaco-
logical and non-pharmacological interventions interact 
with these systems are encouraged.
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